116 related articles for article (PubMed ID: 24462631)
1. Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice.
Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
Exp Eye Res; 2014 Mar; 120():127-37. PubMed ID: 24462631
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mid-pregnant mice with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces abnormal retinal vascular patterning in their newborn pups.
Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):293-9. PubMed ID: 24831925
[TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats.
Nakano A; Nakahara T; Mori A; Ushikubo H; Sakamoto K; Ishii K
Exp Eye Res; 2016 Feb; 143():120-31. PubMed ID: 26500193
[TBL] [Abstract][Full Text] [Related]
4. Effects of KRN633, an inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase, on vascular development of placenta and fetus of mid-pregnancy in mice.
Wada Y; Ozaki H; Abe N; Nagamitsu T; Ohta H; Nakahara T; Ishii K
J Pharmacol Sci; 2010; 112(3):290-8. PubMed ID: 20197639
[TBL] [Abstract][Full Text] [Related]
5. KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces intrauterine growth restriction in mice.
Abe N; Nakahara T; Morita A; Wada Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):297-303. PubMed ID: 23780833
[TBL] [Abstract][Full Text] [Related]
6. Treatment of newborn mice with inhibitors of vascular endothelial growth factor receptor tyrosine kinase induces abnormal retinal vascular patterning.
Morita A; Nakahara T; Ushikubo H; Mori A; Sakamoto K; Ishii K
Biol Pharm Bull; 2014; 37(12):1986-9. PubMed ID: 25451848
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an abnormal vascular patterning model in the mouse retina.
Morita A; Sawada S; Mori A; Arima S; Sakamoto K; Nagamitsu T; Nakahara T
J Pharmacol Sci; 2018 Apr; 136(4):177-188. PubMed ID: 29627228
[TBL] [Abstract][Full Text] [Related]
8. Exposure to high-concentration oxygen in the neonatal period induces abnormal retinal vascular patterning in mice.
Morita A; Ushikubo H; Mori A; Sakamoto K; Nakahara T
Birth Defects Res B Dev Reprod Toxicol; 2016 Dec; 107(6):216-224. PubMed ID: 27792858
[TBL] [Abstract][Full Text] [Related]
9. Effects of mTOR inhibition on normal retinal vascular development in the mouse.
Yagasaki R; Nakahara T; Mori A; Sakamoto K; Ishii K
Exp Eye Res; 2014 Dec; 129():127-34. PubMed ID: 25446323
[TBL] [Abstract][Full Text] [Related]
10. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.
Nakano A; Asano D; Kondo R; Mori A; Arima S; Ushikubo H; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
Exp Eye Res; 2018 Mar; 168():115-127. PubMed ID: 29339088
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats.
Kondo R; Nakano A; Asano D; Morita A; Arima S; Mori A; Sakamoto K; Nagamitsu T; Nakahara T
Biol Pharm Bull; 2020; 43(5):859-863. PubMed ID: 32378561
[TBL] [Abstract][Full Text] [Related]
12. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.
Feeney SA; Simpson DA; Gardiner TA; Boyle C; Jamison P; Stitt AW
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):839-47. PubMed ID: 12556420
[TBL] [Abstract][Full Text] [Related]
13. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina.
Morita A; Ushikubo H; Mori A; Arima S; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
Dev Dyn; 2017 Mar; 246(3):186-200. PubMed ID: 28033674
[TBL] [Abstract][Full Text] [Related]
14. VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the Royal College of Surgeons rat.
Prokosch V; Fink J; Heiduschka P; Melkonyan H; Thanos S
Exp Eye Res; 2011 Feb; 92(2):128-37. PubMed ID: 21147101
[TBL] [Abstract][Full Text] [Related]
15. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
16. Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEGF receptor-2 tyrosine kinase, and identification of its potential therapeutic window.
Matsunaga N; Nakamura K; Yamamoto A; Taguchi E; Tsunoda H; Takahashi K
Mol Cancer Ther; 2006 Jan; 5(1):80-8. PubMed ID: 16432165
[TBL] [Abstract][Full Text] [Related]
17. Regression of retinal capillaries following N-methyl-D-aspartate-induced neurotoxicity in the neonatal rat retina.
Asano D; Nakahara T; Mori A; Sakamoto K; Ishii K
J Neurosci Res; 2015 Feb; 93(2):380-90. PubMed ID: 25284371
[TBL] [Abstract][Full Text] [Related]
18. Transient phenotypic changes in endothelial cells and pericytes in neonatal mouse retina following short-term blockade of vascular endothelial growth factor receptors.
Morita A; Mori A; Arima S; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
Dev Dyn; 2018 May; 247(5):699-711. PubMed ID: 29247590
[TBL] [Abstract][Full Text] [Related]
19. Role of mammalian target of rapamycin in the formation and progression of retinopathy of prematurity-like vascular abnormalities in neonatal rats.
Nakano A; Morita A; Arima S; Nagamitsu T; Nakahara T
Microvasc Res; 2024 Mar; 152():104626. PubMed ID: 37963514
[TBL] [Abstract][Full Text] [Related]
20. Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.
Nakano A; Kondo R; Kaneko Y; Arima S; Asano D; Morita A; Sakamoto K; Nagamitsu T; Nakahara T
Cell Tissue Res; 2020 Mar; 379(3):473-486. PubMed ID: 31788758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
